Thomson AW et al. |
FK 506, cardiac transplantation, and graft-vessel disease. |
1992 |
Lancet |
pmid:1370563
|
Carobbi A et al. |
Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival. |
1992 |
Transplant. Proc. |
pmid:1373543
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Bavandi A et al. |
Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506. |
1992 |
Exp. Dermatol. |
pmid:1285411
|
Takada K et al. |
Distribution kinetics of FK-506, a novel immunosuppressant, after intravenous administration to rats in comparison with cyclosporin A. |
1992 |
Biopharm Drug Dispos |
pmid:1379839
|
Mittrücker HW and Fleischer B |
Functional localization of an exocytosis-triggering G-protein in human cytotoxic T lymphocytes. |
1992 |
Immunology |
pmid:1383135
|
Mizuno K et al. |
Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. |
1992 Jan-Feb |
Anticancer Res. |
pmid:1373592
|
Arai S et al. |
The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine. |
1992 Jul-Aug |
J. Heart Lung Transplant. |
pmid:1379829
|
Fagiuoli S et al. |
FK 506: a new immunosuppressive agent for organ transplantation. Pharmacology, mechanism of action and clinical applications. |
1992 Jul-Aug |
Ital J Gastroenterol |
pmid:1381245
|
Tong J et al. |
Effect of FK-506 and cyclosporin A on in vitro CFU-GM growth in severe aplastic anemia patients. |
1992 Jul-Aug |
Haematologica |
pmid:1385279
|
Nazer H et al. |
FK 506 associated disorders in liver transplantation. |
1992 May-Jun |
J. Gastroenterol. Hepatol. |
pmid:1377038
|
Bowman H and Lennard TW |
Immunosuppressive drugs. |
1992 Nov 4-17 |
Br J Hosp Med |
pmid:1282440
|
Sattler M et al. |
Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. |
1992 Sep-Oct |
Drug Metab. Dispos. |
pmid:1385058
|
Gibbs JF et al. |
Outcome analysis of FK 506 therapy for acute and chronic rejection. |
1993 |
Transplant. Proc. |
pmid:7679823
|
|
Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. |
1993 |
Transplant. Proc. |
pmid:7679824
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Rilo HR et al. |
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. |
1993 |
Transplant. Proc. |
pmid:7680172
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Schweizer M et al. |
Sensitivity of mitochondrial peptidyl-prolyl cis-trans isomerase, pyridine nucleotide hydrolysis and Ca2+ release to cyclosporine A and related compounds. |
1993 |
Biochem. Pharmacol. |
pmid:7680201
|
Demetris AJ et al. |
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. |
1993 |
Transplant. Proc. |
pmid:7505503
|
Pancer Z et al. |
cDNA cloning of a putative protochordate FK506-binding protein. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7505578
|
Fischer S et al. |
A mechanism for rotamase catalysis by the FK506 binding protein (FKBP). |
1993 |
Biochemistry |
pmid:7505615
|
Thomson AW et al. |
ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. |
1993 |
Autoimmunity |
pmid:7505632
|
Woodle ES et al. |
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. |
1993 |
Transplant. Proc. |
pmid:7682360
|
Meiser BM et al. |
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. |
1993 |
Transplant. Proc. |
pmid:7682363
|
Yu Y et al. |
Mutagenicity of the new immunosuppressive drugs, FK 506, and spergualin. |
1993 |
Transplant. Proc. |
pmid:7682364
|
Rao PN et al. |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7682366
|
McCauley J et al. |
Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. |
1993 |
Nephrol. Dial. Transplant. |
pmid:7508098
|
Nishikawa T et al. |
Kinetic analysis of molecular interconversion of immunosuppressant FK506 by high-performance liquid chromatography. |
1993 |
Pharm. Res. |
pmid:7508108
|
Keicho N et al. |
Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. |
1993 |
J. Antibiot. |
pmid:7693639
|
Timerman AP et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. |
1993 |
J. Biol. Chem. |
pmid:7693682
|
Schwaninger M et al. |
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. |
1993 |
J. Biol. Chem. |
pmid:7693684
|
Soldin SJ et al. |
Immunophilin receptors for immunosuppressive drugs. |
1993 |
Ther Drug Monit |
pmid:7510077
|
McMichael J et al. |
Computer-guided concentration-controlled trials in autoimmune disorders. |
1993 |
Ther Drug Monit |
pmid:7510078
|
Ocain TD et al. |
A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7685167
|
Asami M et al. |
Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7685169
|
Fenton M and Kay JE |
Thapsigargin activates lymphocytes via a different pathway from ionomycin. |
1993 |
Biochem. Soc. Trans. |
pmid:7510649
|
Renoir JM et al. |
Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor. |
1993 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7522118
|
Jung-Testas I et al. |
[Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]]. |
1993 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7522119
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
Antoni FA et al. |
Inhibitory role for calcineurin in stimulus-secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7687429
|
Denesyuk AI et al. |
Comparison of conformations of cyclosporin A and macrolide FK506 fragments: localization of putative binding sites with phosphatase calcineurin. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7687433
|
Viebahn R et al. |
Simulation of hypoxic and preservation injury in human hepatocyte cultures: influence of FK 506 and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7689278
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1993 |
Transplant. Proc. |
pmid:7689280
|
Lee KK et al. |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. |
1993 |
Am. J. Surg. |
pmid:7678188
|
Galvin F et al. |
Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. |
1993 |
Eur. J. Immunol. |
pmid:7678228
|
Foxwell BM et al. |
Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506. |
1993 |
Eur. J. Immunol. |
pmid:7678231
|
Hirai T et al. |
Prolonged lung allograft survival with a short course of FK 506. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7678313
|